Historical Bibliography Updated: June 17, 2026
Un nouveau médicament symptomatique des syndromes parkinsoniens: le chlorhydrate de [(diéthylamino-2’-methyl-2’) éthyl-1-’] N-dibenzoparathiazine.
Publication Details
Presse méd., 57, 819-20. 1949 CE.
Introduction of ethopropazine (“lysivane”) in the treatment of Parkinson’s disease.
Browse Tags
Thematic Classifications
| Catalog Metadata | Reference Information |
|---|---|
| Entry Number | #4728 |
| Permanent Link | https://hom-sveltekit.fly.dev/entry/1244 |
| External URL | un-nouveau-mdicament-symptomatique-des-syndromes-parkinsoniens-le-chlorhydrate-de-dithylamino2methyl2-thyl1-ndibenzoparathiazine |